Daily non-political popular news in brief.
MS patients not receiving medications to slow disease progression, research shows
04-16-2007 · EurekAlert!Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis are not taking or being prescribed drugs approved to treat the disease.
Read more »
Keywords: patients, receiving, medications, slow, disease, progression, research, shows, patient, medication, show
« Previous | Next »
Similar news on "MS patients not receiving medications to slow disease progression, research shows":
- New type of drug shows promise in attacking melanoma in an innovative way
09-26-2007 · EurekAlert!
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. New research presented today at the European Cancer Conference in Barcelona found that giving the new drug in addition to chemotherapy more than doubled the amount of time patients survived without progression of their cancer.
Similar news · Read more »
- Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
10-31-2006 · EurekAlert!
Scientists have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer. They looked at cancer cells from more than 2,000 breast cancer patients and found that this commandeering or "organizing" ability is increasingly lost in cancer cells and associated with the progression of disease. The more the gene is expressed in breast cancer, the better the patient did.
Similar news · Read more »
- Breakthrough MS treatment doesn't reach US patients
04-04-2007 · EurekAlert!
Many US multiple sclerosis (MS) patients aren't receiving the latest drug therapies, according to research published in the online journal BMC Medicine. Immunomodulatory agents (IMAs) could slow the progress of the disease, but are only prescribed in a minority of cases, and mostly by neurologists.
Similar news · Read more »
- Pancreatic cancer vaccine halts progression of disease in some patients
04-17-2007 · EurekAlert!
A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
Similar news · Read more »
- CCFA survey finds the majority of ulcerative colitis patients are not compliant with medications
12-19-2006 · EurekAlert!
A new, large survey supported by the Crohn's & Colitis Foundation of America (CCFA) finds that 65 percent of ulcerative colitis patients are less than fully compliant with first-line therapies to treat their disease.The most commonly reported reasons for noncompliance with medications were the dosing frequency, the number of pills and the inconvenience associated with the medication.
Similar news · Read more »
- New drug therapy to combat GVHD in stem-cell patients shows significant reduction in deaths
01-23-2007 · EurekAlert!
Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers. Now, new research from Fred Hutchinson Cancer Research Center shows that adding a widely used topical corticosteroid to the standard treatment for GVHD kept the disease in remission and significantly reduces deaths one year after therapy.
Similar news · Read more »
- New study reveals gender disparity in anti-TNF treatment for rheumatoid arthritis
06-14-2007 · EurekAlert!
Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs -- very effective but expensive modern medications against this disease -- at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.
Similar news · Read more »
- Research shows new therapy is effective for patients with Crohn's disease
07-18-2007 · EurekAlert!
Mayo Clinic researchers have found that Certolizumab pegol is an effective treatment for adults with Crohn's disease, according to two new studies. These findings were published in today's issue of the New England Journal of Medicine. Certolizumab pegol blocks tumor necrosis factor, an important cause of inflammation in Crohn's disease
Similar news · Read more »
- Study reveals differences in cancer stage presentation between rural and urban patients
11-09-2007 · EurekAlert!
New research published in the November issue of the Journal of the American College of Surgeons shows that urban colorectal and lung cancer patients present at later stages of disease than rural patients do. This finding is contrary to the common assumption that rural patients with cancer present at a later stage of disease in comparison with urban patients.
Similar news · Read more »
- Breathe deep: Which patients could benefit from inhaled steroids in cystic fibrosis?
11-28-2007 · EurekAlert!
A specific variation in the glucocorticoid receptor gene is associated with lung disease progression in cystic fibrosis, research published this week in the online open access journal Respiratory Research reveals. This finding adds weight to previous research suggesting that specific subgroups of patients with cystic fibrosis may benefit from glucocorticoid treatment.
Similar news · Read more »
